GHTC is working to advance new funding and policy solutions to accelerate the development of technologies to fight COVID-19 in low-resource settings and ensure equitable access to these tools. Learn more about our ongoing advocacy work.
Learn moreGHTC has created a new resource tracking the current state of R&D efforts to combat COVID-19. The tracker, which will be updated regularly, includes information on R&D efforts supported by the US government, multilateral institutions, and GHTC member organizations.
ViewBD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care, as well as supporting frontline health care workers by developing innovative solutions that help advance both clinical therapy for patients and clinical process for health care providers.
Learn More
Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.
Learn More
GHTC joined a civil society statement from the Global Health Council—in response to the special session of the World Health Organization (WHO) Executive Board (EB)—imploring WHO member states to take urgent action to accelerate the development and equitable global delivery of COVID-19 technologies.
PDF
GHTC issued the following statement regarding the release of the revised House Heroes Act released yesterday. GHTC applauds the inclusion of emergency funding to support the international response to COVID-19 and urges congressional champions to support additional investment opportunities to resource the US Agency for International Development (USAID)’s Global Health Bureau to advance COVID-19 technologies.
Learn more
GHTC endorsed a Global Health Council letter urging Congress to allocate at least US$20 billion in emergency supplemental funding for programs funded through the International Affairs Budget, including at least $11 billion for bilateral global health programs and the multilateral response to support a holistic global response to COVID-19.
PDF
Drugs for Neglected Diseases initiative, COVID-19 Clinical Research Coalition
Virtual
View
Government of Japan, Access and Delivery Partnership (ADP), GHIT Fund
Virtual
View
American Society of Tropical Medicine & Hygiene
Virtual
View
Are these innovations real, or are we pulling one over on you? Test your knowledge of global health technologies with our Halloween game, TRICK or TREATment.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
